Filing
Spy
Filing
Spy
Home
About
AVXS
Avexis Inc
Gene therapy company developing treatments for rare neurological genetic diseases
CUSIP: 05366U100
Healthcare
US
1 holder
Ownership
Activity
2017 Q3
3 of 5 quarters
Total Value
$57.20M
Total Shares
591.4K
Net Share Change
-301.9K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$57.20M
591.4K
0.4%
TRIM
-301.9K
(-33.8%)
Viking Global Investors
$57.20M
591.4K shares
TRIM
-301.9K
(-33.8%)
AVXS — Avexis Inc - FilingSpy